Will it surge ,substantial uptrend, bullish possible spike this afternoon

**The possibility of a surge, substantial uptrend, or bullish spike in Edgewise Therapeutics (EWTX) this afternoon cannot be predicted with certainty**, but several factors suggest that such an event might not occur: 1. **Market Dynamics**: The stock market, including the pharmaceutical sector, can experience sudden volatility due to various factors such as economic data releases, geopolitical events, or investor sentiment shifts. However, without specific news or events driving market activity, it's challenging to predict a substantial uptrend or spike. 2. **Company-Specific News**: While EWTX has recently reported positive developments in its HCM treatment, these announcements are not expected to occur again today. The absence of new catalysts could limit the stock's upward momentum. 3. **Technical Indicators**: The technical analysis of EWTX shows a resistance level at $26.91, which may act as a barrier to any potential upward movement. Additionally, the stock's recent trading volume was lower than average, indicating a lack of strong buying pressure. 4. **Analyst Expectations**: Analysts have raised their price targets for EWTX, but these expectations are based on a longer-term perspective. It is unlikely that analysts expect a sudden, substantial surge in the stock price. 5. **Investor Sentiment**: The recent insider selling by John R. Moore, the General Counsel of EWTX, could indicate a lack of confidence in the stock's short-term performance. This sentiment may not contribute to a bullish atmosphere. In conclusion, while it is theoretically possible for EWTX to experience a surge, substantial uptrend, or bullish spike this afternoon, the available information suggests that such an event is unlikely. Investors should monitor the stock closely for any unexpected developments that could alter the trajectory of its price.